Stomatal conductance, photosynthetic assimilation rates and pre-dawn water potential were measured just before imposition of water stress (8th of August) and during the stress period at periodic intervals from both stressed and control plants.
Dexmedetomidine, with its longer action duration compared to remifentanil, may have reduced the "no pain control period" interval and the time from discontinuation of the adjuvant in propofol-based TIVA to PCA initiation, thereby increasing the stimulus threshold and resulting in a reduced VAS score and PCA requirement.
Although pannus ingrowth can occur in the late postoperative period (mean interval from previous operation 9.6 ± 2.0 years reported by Kuniyoshi et al. [ 33]), valve-related complications due to pannus formation are rare (incidence 0.2 4.5 % per patient year [ 34]) and scarcely an issue with contemporary mechanical prostheses.
Patients in the intervention group were offered £15 for each injection of antipsychotic drug over a 12 month period (intervals between injections ranging from one to four weeks).
Another statistic that has been hard to calculate for SARS is the incubation period -- the interval from the time of exposure to the onset of symptoms -- because individuals may have been exposed to the virus on a number of occasions.
However, for the biggest values of the period in the interval from 7 to 14 slot times, the standard deviation is equal to 160 for the Random Walk model and 106 for the Gauss Markov model.
Importantly, the incubation period (the mean interval from exposure to average of seroconversion and ALT elevation) was exactly the same (4.25 weeks) when exactly the same challenge dose (105.0 ID50) of HAV and HEV were administered to pairs of tamarins and rhesus monkeys, respectively (and Figure 4A and 4B).
When considering those 11 progressors who tested positive for at least one diabetes-associated autoantibody in the pre-diabetic period, the median interval from the first antibody-positive sample to the diagnosis of diabetes was 8.9 years with a minimum of <1 year and a maximum of 20 years.
Cohort expansion took place only if dose-limiting toxicity (DLT) was reported in one patient for each cohort during the tolerability evaluation period (defined as the interval from the first dose of tivantinib to day 29 of the combination therapy).
Secondary outcomes were an offer of screening to women before 10 weeks' gestation; gestational age at testing, as calculated by time from the date of the last menstrual period to screening; mean interval from first visit to the general practice to screening; and women's knowledge of the carrier status of their baby's father by 11 weeks' (77 days') gestation.
